COM362d43
Homo sapiens
source_name
BL0269 human bladder cancer patient-derived xenograft (PDX)
phenotype
Combination (cisplatin+pictilisib) treatment-resistant
drug treatment
Combination treatment (cisplatin+pictilisib)
duration of drug treatment
43 days